Reuters logo
BRIEF-Sihuan Pharmaceutical says CFDA granted approval of phase I-III clinical trials of Birociclib
July 12, 2017 / 12:09 PM / 2 months ago

BRIEF-Sihuan Pharmaceutical says CFDA granted approval of phase I-III clinical trials of Birociclib

July 12 (Reuters) - Sihuan Pharmaceutical Holdings Group Ltd :

* China Food and Drug Administration has granted approval of phase I-III clinical trials of Birociclib Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below